BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7891820)

  • 1. Platelet protein kinase C levels in Alzheimer's disease.
    Matsushima H; Shimohama S; Tanaka S; Taniguchi T; Hagiwara M; Hidaka H; Kimura J
    Neurobiol Aging; 1994; 15(6):671-4. PubMed ID: 7891820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of protein kinase C isozymes by two-site enzyme immunoassay in human brains and changes in Alzheimer's disease.
    Shimohama S; Narita M; Matsushima H; Kimura J; Kameyama M; Hagiwara M; Hidaka H; Taniguchi T
    Neurology; 1993 Jul; 43(7):1407-13. PubMed ID: 8327146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of chronic lithium treatment on platelet PKC isozymes in Alzheimer's and elderly control subjects.
    Molchan SE; Manji H; Chen G; Dou L; Little J; Potter WZ; Sunderland T
    Neurosci Lett; 1993 Nov; 162(1-2):187-91. PubMed ID: 8121626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of platelet phospholipase C activity in patients with Alzheimer disease.
    Matsushima H; Shimohama S; Fujimoto S; Takenawa T; Kimura J
    Alzheimer Dis Assoc Disord; 1995; 9(4):213-7. PubMed ID: 8749610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein kinase C activity and protein levels in Alzheimer's disease.
    Lanius RA; Wagey R; Sahl B; Beattie BL; Feldman H; Pelech SL; Krieger C
    Brain Res; 1997 Aug; 764(1-2):75-80. PubMed ID: 9295195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alteration of human platelet protein kinase C with normal aging.
    Matsushima H; Shimohama S; Yamaoka Y; Kimura J; Taniguchi T; Hagiwara M; Hidaka H
    Mech Ageing Dev; 1993 Jun; 69(1-2):129-36. PubMed ID: 8377527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein kinase C-zeta activity but not level is decreased in Alzheimer's disease microvessels.
    Moore P; White J; Christiansen V; Grammas P
    Neurosci Lett; 1998 Sep; 254(1):29-32. PubMed ID: 9780084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ca2+-dependent and Ca2+-independent protein kinase C changes in the brain of patients with Alzheimer's disease.
    Matsushima H; Shimohama S; Chachin M; Taniguchi T; Kimura J
    J Neurochem; 1996 Jul; 67(1):317-23. PubMed ID: 8667008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attenuated protein kinase C activity and translocation in Alzheimer's disease brain.
    Wang HY; Pisano MR; Friedman E
    Neurobiol Aging; 1994; 15(3):293-8. PubMed ID: 7936052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in platelet phospholipase C protein level and activity in Alzheimer's disease.
    Matsushima H; Shimohama S; Fujimoto S; Takenawa T; Kimura J
    Neurobiol Aging; 1995; 16(6):895-900. PubMed ID: 8622779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization and differential distribution of the three major human protein kinase C isozymes (PKC alpha, PKC beta, and PKC gamma) of the central nervous system in normal and Alzheimer's disease brains.
    Clark EA; Leach KL; Trojanowski JQ; Lee VM
    Lab Invest; 1991 Jan; 64(1):35-44. PubMed ID: 1990207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of protein kinase C by short term hyperglycaemia in human platelets in vivo and in vitro.
    Assert R; Scherk G; Bumbure A; Pirags V; Schatz H; Pfeiffer AF
    Diabetologia; 2001 Feb; 44(2):188-95. PubMed ID: 11270675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein kinase C anchoring deficit in postmortem brains of Alzheimer's disease patients.
    Battaini F; Pascale A; Lucchi L; Pasinetti GM; Govoni S
    Exp Neurol; 1999 Oct; 159(2):559-64. PubMed ID: 10506528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet phosphatidylinositol kinase activity is not altered in Alzheimer disease.
    Bothmer J; Markerink M; Coppens R; Jolles J
    Mol Chem Neuropathol; 1993 Aug; 19(3):249-57. PubMed ID: 8397585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytochrome c oxidase and mitochondrial F1F0-ATPase (ATP synthase) activities in platelets and brain from patients with Alzheimer's disease.
    Bosetti F; Brizzi F; Barogi S; Mancuso M; Siciliano G; Tendi EA; Murri L; Rapoport SI; Solaini G
    Neurobiol Aging; 2002; 23(3):371-6. PubMed ID: 11959398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of protein kinase C mRNA levels in Alzheimer's disease brains.
    Chachin M; Shimohama S; Kunugi YU; Taniguchi T
    Jpn J Pharmacol; 1996 Jun; 71(2):175-7. PubMed ID: 8835644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein kinase C in platelets of depressed patients.
    Pandey GN; Dwivedi Y; Kumari R; Janicak PG
    Biol Psychiatry; 1998 Nov; 44(9):909-11. PubMed ID: 9807646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in signal transduction in Alzheimer's disease.
    Shimohama S; Ninomiya H; Saitoh T; Terry RD; Fukunaga R; Taniguchi T; Fujiwara M; Kimura J; Kameyama M
    J Neural Transm Suppl; 1990; 30():69-78. PubMed ID: 2391515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered platelet protein kinase C activity in bipolar affective disorder, manic episode.
    Friedman E; Hoau-Yan-Wang ; Levinson D; Connell TA; Singh H
    Biol Psychiatry; 1993 Apr; 33(7):520-5. PubMed ID: 8513036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein kinase C-delta activation and tyrosine phosphorylation in platelets.
    Moussazadeh M; Haimovich B
    FEBS Lett; 1998 Nov; 438(3):225-30. PubMed ID: 9827550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.